Evaluation of the antioxidative properties of lipoxygenase inhibitors

Pharmacological Reports

Volumn 64, Issue 5, 2012, Pages 1179-1188

  Czapski, Grzegorz A ^a   Czubowicz, Kinga ^a   Strosznajder, Robert P ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Antioxidant; Free radical scavenger; Lipoxygenase; Oxidative stress; Reactive oxygen species

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2 (12 HYDROXYDODECA 5,10 DIYNYL) 3,5,6 TRIMETHYL 4 BENZOQUINONE; ANTIOXIDANT; ASCORBIC ACID; BAICALEIN; BWB 70C; CARBONYL DERIVATIVE; DOCEBENONE; FREE RADICAL; IRON; LIPOXYGENASE INHIBITOR; N [3 [3 (4 FLUOROPHENOXY)PHENYL] 1 METHYL 2 PROPENYL] N HYDROXYUREA; NORDIHYDROGUAIARETIC ACID; RESVERATROL; TROLOX C; UNCLASSIFIED DRUG; ZILEUTON;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL FREE SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN METABOLISM; RAT; TISSUE HOMOGENATE;

EID: 84873721403     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/s1734-1140(12)70914-3     Document Type: Article

References (52)

1. Aizu E, Nakadate T, Yamamoto S, Kato R: Inhibition of 12-O-tetradecanoylphorbol-13-acetate-mediated epidermal ornithine decarboxylase induction and skin tumor promotion by new lipoxygenase inhibitors lacking protein kinase C inhibitory effects. Carcinogenesis, 1986, 7, 1809-1812.
2. Ancill RJ, Takahashi Y, Kibune Y, Campbell R, Smith JR. Randomized double-blind, placebo-controlled clinical trial of a selective 5-lipoxygenase inhibitor (AA-861) for the prevention of seasonal allergic rhinitis. J Int Med Res, 1990, 18, 75-88. (Pubitemid 20123933)
3. Asakawa T, Matsushita S: Coloring conditions of thiobarbituric acid test for detecting lipid peroxides. Lipids, 1980, 15, 137-140. (Pubitemid 10054160)
4. Cao G, Sofic E, Prior RL. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med, 1997, 22, 749-760. (Pubitemid 27058337)
5. Carter GW, Young PR, Albert DH, Bouska J, Dyer R, Bell RL, Summers JB, Brooks DW: 5-Lipoxygenase inhibitory activity of zileuton. J Pharmacol Exp Ther, 1991, 256, 929-937.
6. Cheng Y, He G, Mu X, Zhang T, Li X, Hu J, Xu B, Du G: Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile. Neurosci Lett, 2008, 441, 16-20.
7. Chou DS, Hsiao G, Lai YA, Tsai YJ, Sheu JR: Baicalein induces proliferation inhibition in B16F10 melanoma cells by generating reactive oxygen species via 12- lipoxygenase. Free Radic Biol Med, 2009, 46, 1197-1203.
8. Chou DS, Lee JJ, Hsiao G, Hsieh CY, Tsai YJ, Chen TF, Sheu JR: Baicalein induction of hydroxyl radical formation via 12-lipoxygenase in human platelets: an ESR study. J Agric Food Chem, 2007, 55, 649-655.
9. Chow JM, Shen SC, Wu CY, Chen YC: 12-o-Tetradecanoylphorbol 13-acetate prevents baicalein-induced apoptosis via activation of protein kinase C and JNKs in human leukemia cells. Apoptosis, 2006, 11, 1999-2011.
10. Coffey MJ, Phare SM, Peters-Golden M: Interaction between nitric oxide, reactive oxygen intermediates, and peroxynitrite in the regulation of 5-lipoxygenase metabolism. Biochim Biophys Acta, 2002, 1584, 81-90. (Pubitemid 35217880)
11. Cominacini L, Pasini AF, Garbin U, Davoli A, Tosetti ML, Campagnola M, Rigoni A et al.: Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-1 in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species. J Biol Chem, 2000, 275, 12633-12638. (Pubitemid 30241412)
12. Czapski GA, Cakala M, Gajkowska B, Strosznajder JB: Poly(ADP-ribose) polymerase-1 inhibition protects the brain against systemic inflammation. Neurochem Int, 2006, 49, 751-755. (Pubitemid 44648493)
13. Czapski GA, Cakala M, Kopczuk D, Strosznajder JB: Effect of poly(ADP-ribose) polymerase inhibitors on oxidative stress evoked hydroxyl radical level and macromolecules oxidation in cell free system of rat brain cortex. Neurosci Lett, 2004, 356, 45-48. (Pubitemid 38121503)
14. Czapski GA, Sun GY, Strosznajder JB: Inhibition of N-methyl-D-aspartic acid-nitric oxide synthase in rat hippocampal slices by ethanol. Evidence for the involvement of tetrahydrobiopterin but not lipid peroxidation. J Biomed Sci, 2002, 9, 3-9. (Pubitemid 34124201)
15. Czubowicz K, Czapski GA, Cieoelik M, Strosznajder RP: Lipoxygenase inhibitors protect brain cortex macromolecules against oxidation evoked by nitrosative stress. Folia Neuropathol, 2010, 48, 283-292.
16. Deschamps JD, Kenyon VA, Holman TR: Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenases. Bioorg Med Chem, 2006, 14, 4295-4301.
17. Empfield JR, Leeson PD: Lessons learned from candidate drug attrition. IDrugs, 2010, 13, 869-873.
18. Firuzi O, Zhuo J, Chinnici CM, Wisniewski T, Praticò D: 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease. FASEB J, 2008, 22, 1169-1178. (Pubitemid 351519971)
19. Fischer AS, Metzner J, Steinbrink SD, Ulrich S, Angioni C, Geisslinger G, Steinhilber D, Maier TJ: 5-Lipoxygenase inhibitors induce potent anti-proliferative and cytotoxic effects in human tumour cells independently of suppression of 5-lipoxygenase activity. Br J Pharmacol, 2010, 161, 936-949.
20. Friedlander TW, Weinberg VK, Huang Y, Mi JT, Formaker CG, Small EJ, Harzstark AL et al.: A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate cancer. Oncol Rep, 2012, 27 3-9.
21. Gabryel B, Bielecka A, Bernacki J, Łabuzek K, Herman ZS: Immunosuppressant cytoprotection correlates with HMGB1 suppression in primary astrocyte cultures exposed to combined oxygen-glucose deprivation. Pharmacol Rep, 2011, 63, 392-402.
22. Gao D, Sakurai K, Katoh M, Chen J, Ogiso T: Inhibition of microsomal lipid peroxidation by baicalein: a possible formation of an iron-baicalein complex. Biochem Mol Biol Int, 1996, 39, 215-225. (Pubitemid 26202736)
23. Gasiorowski K, Lamer-Zarawska E, Leszek J, Parvathaneni K, Yendluri BB, Błach-Olszewska Z, Aliev G. Flavones from root of Scutellaria baicalensis Georgi: drugs of the future in neurodegeneration? CNS Neurol Disord Drug Targets, 2011, 10, 184-191.
24. Guzmán-Beltrán S, Espada S, Orozco-Ibarra M, Pedraza-Chaverri J, Cuadrado A: Nordihydroguaiaretic acid activates the antioxidant pathway Nrf2/HO-1 and protects cerebellar granule neurons against oxidative stress. Neurosci Lett, 2008, 447, 167-171.
25. Hada T, Ueda N, Takahashi Y, Yamamoto S: Catalytic properties of human platelet 12-lipoxygenase as compared with the enzymes of other origins. Biochim Biophys Acta, 1991, 1083, 89-93.
26. th edn., Oxford University Press Inc., New York, 2007.
27. Hope WC, Welton AF, Fiedler-Nagy C, Batula-Bernardo C, Coffey JW: In vitro inhibition of the biosynthesis of slow reacting substance of anaphylaxis (SRS-A) and lipoxygenase activity by quercetin. Biochem Pharmacol, 1983, 32, 367-371. (Pubitemid 13184478)
28. Hu B, Li D, Sawamura T, Mehta JL: Oxidized LDL through LOX-1 modulates LDL-receptor expression in human coronary artery endothelial cells. Biochem Biophys Res Commun, 2003, 307, 1008-1012. (Pubitemid 36871673)
29. Ishige K, Schubert D, Sagara Y: Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic Biol Med, 2001, 30, 433-446. (Pubitemid 32155542)
30. Jatana M, Giri S, Ansari MA, Elango C, Singh AK, Singh I, Khan M: Inhibition of NF-κB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. J Neuroinflammation, 2006, 3, 12.
31. Lebeau A, Esclaire F, Rostène W, Pélaprat D: Baicalein protects cortical neurons from beta-amyloid (25-35) induced toxicity: Neuroreport, 2001, 12, 2199-2202. (Pubitemid 32646272)
32. Lepley RA, Fitzpatrick FA. 5-Lipoxygenase compartmentalization in granulocytic cells is modulated by an internal bipartite nuclear localizing sequence and nuclear factor kappa B complex formation. Arch Biochem Biophys, 1998, 356, 71-76. (Pubitemid 28364356)
33. Li CT, Zhang WP, Lu YB, Fang SH, Yuan YM, Qi LL, Zhang LH et al.: Oxygen-glucose deprivation activates 5-lipoxygenase mediated by oxidative stress through the p38 mitogen-activated protein kinase pathway in PC12 cells. J Neurosci Res, 2009, 87, 991-1001.
34. Listì F, Caruso C, Lio D, Colonna-Romano G, Chiappelli M, Licastro F, Candore G: Role of cyclooxygenase-2 and 5-lipoxygenase polymorphisms in Alzheimer's disease in a population from northern Italy: implication for pharmacogenomics. J Alzheimers Dis, 2010, 19, 551-557.
35. Lü JM, Nurko J, Weakley SM, Jiang J, Kougias P, Lin PH, Yao Q, Chen C: Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit, 2010, 16, RA93-100.
36. Manev H, Chen H, Dzitoyeva S, Manev R: Cyclooxygenases and 5-lipoxygenase in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry, 2011, 35, 315-319.
37. Nakadate T, Yamamoto S, Aizu E, Kato R: Inhibition of mouse epidermal 12-lipoxygenase by 2,3,4-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4- benzoquinone (AA861). J Pharm Pharmacol, 1985, 37, 71-73. (Pubitemid 15199341)
38. Oliver CN, Ahn BW, Moerman EJ, Goldstein S, Stadtman ER: Age-related changes in oxidized proteins. J Biol Chem, 1987, 262, 5488-2491.
39. Oliveira MW, Minotto JB, de Oliveira MR, Zanotto-Filho A, Behr GA, Rocha RF, Moreira JC, Klamt F: Scavenging and antioxidant potential of physiological taurine concentrations against different reactive oxygen/nitrogen species. Pharmacol Rep, 2010, 62, 185-193.
40. Pavani M, Fones E, Oksenberg D, Garcia M, Hernandez C, Cordano G, Muñoz S et al.: Inhibition of tumoral cell respiration and growth by nordihydroguaiaretic acid. Biochem Pharmacol, 1994, 48, 1935-1942. (Pubitemid 24355022)
41. Payne AN, Jackson WP, Salmon JA, Nicholls A, Yeadon M, Garland LG: Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl, 1991, 34, 189-199.
42. Perez-Polo JR, Reilly CB, Rea HC: Oxygen resuscitation after hypoxia ischemia stimulates prostaglandin pathway in rat cortex. Int J Dev Neurosci, 2011, 29, 639-644.
43. Read NG, Astbury PJ, Evans GO, Goodwin DA, Rowlands A. Nephrotic syndrome associated with N-hydroxyureas, inhibitors of 5-lipoxygenase. Arch Toxicol, 1995, 69, 480-490.
44. Schumock GT, Lee TA, Joo MJ, Valuck RJ, Stayner LT, Gibbons RD: Association between leukotrienemodifying agents and suicide: what is the evidence? Drug Saf, 2011, 34, 533-544.
45. Shieh DE, Liu LT, Lin CC: Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res, 2000, 20, 2861-2865.
46. Strosznajder JB, Cieslik M, Cakala M, Jesko H, Eckert A, Strosznajder RP: Lipoxygenases and poly(ADP-ribose) polymerase in amyloid beta cytotoxicity. Neurochem Res, 2011, 36, 839-848.
47. Strosznajder RP, Gadamski R, Czapski GA, Jesko H, Strosznajder JB: Poly(ADP-ribose) polymerase during reperfusion after transient forebrain ischemia: its role in brain edema and cell death. J Mol Neurosci, 2003, 20, 61-72.
48. van Leyen K, Arai K, Jin G, Kenyon V, Gerstner B, Rosenberg PA, Holman TR, Lo EH: Novel lipoxygenase inhibitors as neuroprotective reagents. J Neurosci Res, 2008, 86, 904-909. (Pubitemid 351357770)
49. Vanags DM, Larsson P, Feltenmark S, Jakobsson PJ, Orrenius S, Claesson HE, Aguilar-Santelises M: Inhibitors of arachidonic acid metabolism reduce DNA and nuclear fragmentation induced by TNF plus cycloheximide in U937 cells. Cell Death Differ, 1997, 4, 479-486. (Pubitemid 127680683)
50. Wang X, Walsh LP, Reinhart AJ, Stocco DM: The role of arachidonic acid in steroidogenesis and steroidogenic acute regulatory (StAR) gene and protein expression. J Biol Chem, 2000, 275, 20204-20209. (Pubitemid 30441632)
51. Watkins PB, Dube LM, Walton-Bowen K, Cameron CM, Kasten LE. Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma. Drug Saf, 2007, 30, 805-815. (Pubitemid 47347353)
52. Yoshimoto T, Yokoyama C, Ochi K, Yamamoto S, Maki Y, Ashida Y, Terao S, Shiraishi M: 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Biochim Biophys Acta, 1982, 713, 470-473. (Pubitemid 13222960)